Remedent, Inc. Stock Other OTC
Equities
REMI
US75954T1043
Medical Equipment, Supplies & Distribution
Financials (USD)
Sales 2022 | 402K | Sales 2023 | 46.11K | Capitalization | 3.07M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | 7.44 x |
Net cash position 2022 | 2.52K | Net cash position 2023 | 27.69K | EV / Sales 2023 | 65.9 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-
| Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.46% |
Managers | Title | Age | Since |
---|---|---|---|
Guy de Vreese
CEO | Chief Executive Officer | 69 | 02-03-31 |
Director of Finance/CFO | 59 | 05-03-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Kolsteeg
BRD | Director/Board Member | 81 | 02-03-31 |
Guy de Vreese
CEO | Chief Executive Officer | 69 | 02-03-31 |
Director of Finance/CFO | 59 | 05-03-29 |
1st Jan change | Capi. | |
---|---|---|
-2.25% | 187B | |
-1.32% | 108B | |
-3.92% | 67.71B | |
+7.99% | 53.07B | |
+15.74% | 47.36B | |
+6.01% | 39.73B | |
+10.81% | 28.56B | |
+2.34% | 26.55B | |
+15.97% | 25.13B |